EUVIMEDEUVIMED entdecken
Video/AudioStudienprotokoll

A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects

Yanlei Wu, Wangjia Ma

Journal of Visualized Experiments · 2026

DOI: 10.3791/70785 ↗

Kurz gefasst

Video/Audio in der Zeitschrift Journal of Visualized Experiments, 2026. Verfasst von Yanlei Wu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Haiyan County People's Hospital. Hauptthemen laut MEDLINE: Finasteride, Prostatic Hyperplasia, Prazosin, Gonadal Steroid Hormones. Die Arbeit nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FinasterideProstatic HyperplasiaPrazosinGonadal Steroid HormonesHumansMaleMiddle AgedAgedPropensity ScoreRetrospective Studies5-alpha Reductase InhibitorsDrug Therapy, Combination

Substanzen

FinasterideTerazosinPrazosinGonadal Steroid Hormones5-alpha Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Urology, Haiyan County People's Hospital.
  • Department of Urology, Haiyan County Traditional Chinese Medical Hospital; mwjia1986@hotmail.com.

Zitieren

APA

Wu, Y., & Ma, W. (2026). A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects. Journal of Visualized Experiments. https://doi.org/10.3791/70785

Vancouver

Wu Y, Ma W. A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects. Journal of Visualized Experiments. 2026. doi:10.3791/70785

BibTeX
@article{Wu2026,
  author = {Wu, Yanlei and Ma, Wangjia},
  title = {A Propensity Score-Matched Protocol: Terazosin Plus Finasteride For Benign Prostatic Hyperplasia – Sex Hormone And Urinary Control Effects},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/70785}
}
Kostenlos starten →